Estrasorb.
Novovax Inc has developed and launched Estrasorb, a transdermally absorbed, micro-encapsulated estradiol, as an estrogen replacement therapy for short-term use in the reduction of vasomotor symptoms in menopausal women. Estrasorb was launched in the US in April 2004.
University of Bari, Department of Obstetrics and Gynecology, Corso Alcide de Gasperi 495, 70125 Bari, Italy. m.chiechi@gynecology3.uniba.it
L Mario
LM
Chiechi
D000279:Administration, Cutaneous; D002986:Clinical Trials as Topic; D004958:Estradiol / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy / Q000379:methods; D005260:Female; D019584:Hot Flashes / Q000188:drug therapy*; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged
D004958:Estradiol